Showing results (241-250 of 9,917) with videos related to
Sort By:
Pageof 992
Bone Marrow Transplantation|July 25, 2006
Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantationK Weichman, L M Dember, T Prokaeva, et al.Bone Marrow Transplantation|June 22, 2006
Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantationC Lengerke, T Ljubicic, C Meisner, et al.Bone Marrow Transplantation|June 22, 2006
Apoptotic lymphocytes and CD34+ cells in cryopreserved cord blood detected by the fluorescent vital dye SYTO 16 and correlation with loss of L-selectin (CD62L) expressionR L Sparrow, H Komodromou, E Tippett, et al.Bone Marrow Transplantation|August 3, 2006
Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patientsP Quittet, P Ceballos, E Lopez, et al.Bone Marrow Transplantation|May 8, 2007
Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remissionY Loh, Y Oyama, L Statkute, et al.Bone Marrow Transplantation|January 1, 1991
Approaches to the evaluation of growth and growth disorders in children after bone marrow transplantation (BMT)M B Ranke, R Dopfer, W F Blum, et al.Bone Marrow Transplantation|May 29, 2007
Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failureJ J Boelens, R F Wynn, A O'Meara, et al.Bone Marrow Transplantation|May 29, 2007
Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimenS D Smith, B J Bolwell, L A Rybicki, et al.Bone Marrow Transplantation|May 29, 2007
Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphomaM Tomblyn, L J Burns, B Blazar, et al.Bone Marrow Transplantation|June 6, 2007
Treatment of refractory chronic GVHD with rituximab: a GITMO studyF Zaja, A Bacigalupo, F Patriarca, et al.Pageof 992